Pregabalin Pfizer

Land: Europeiska unionen

Språk: engelska

Källa: EMA (European Medicines Agency)

Köp det nu

Bipacksedel Bipacksedel (PIL)
12-01-2024
Produktens egenskaper Produktens egenskaper (SPC)
12-01-2024

Aktiva substanser:

pregabalin

Tillgänglig från:

Upjohn EESV

ATC-kod:

N03AX16

INN (International namn):

pregabalin

Terapeutisk grupp:

Antiepileptics,

Terapiområde:

Anxiety Disorders; Epilepsy

Terapeutiska indikationer:

Neuropathic painPregabalin Pfizer is indicated for the treatment of peripheral and central neuropathic pain in adults.EpilepsyPregabalin Pfizer is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.Generalised Anxiety DisorderPregabalin Pfizer is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Produktsammanfattning:

Revision: 29

Bemyndigande status:

Authorised

Tillstånd datum:

2014-04-10

Bipacksedel

                                56
B. PACKAGE LEAFLET
57
PACKAGE LEAFLET: INFORMATION FOR THE USER
PREGABALIN PFIZER 25 MG HARD CAPSULES,
PREGABALIN PFIZER 50 MG HARD CAPSULES,
PREGABALIN PFIZER 75 MG HARD CAPSULES,
PREGABALIN PFIZER 100 MG HARD CAPSULES,
PREGABALIN PFIZER 150 MG HARD CAPSULES,
PREGABALIN PFIZER 200 MG HARD CAPSULES,
PREGABALIN PFIZER 225 MG HARD CAPSULES,
PREGABALIN PFIZER 300 MG HARD CAPSULES
pregabalin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU
.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Pregabalin Pfizer is and what it is used for
2.
What you need to know before you take Pregabalin Pfizer
3.
How to take Pregabalin Pfizer
4.
Possible side effects
5.
How to store Pregabalin Pfizer
6.
Contents of the pack and other information
1.
WHAT PREGABALIN PFIZER IS AND WHAT IT IS USED FOR
Pregabalin Pfizer belongs to a group of medicines used to treat
epilepsy, neuropathic pain and
Generalised Anxiety Disorder (GAD) in adults.
PERIPHERAL AND CENTRAL NEUROPATHIC PAIN:
Pregabalin Pfizer is used to treat long lasting pain caused
by damage to the nerves. A variety of diseases can cause peripheral
neuropathic pain, such as diabetes
or shingles. Pain sensations may be described as hot, burning,
throbbing, shooting, stabbing, sharp,
cramping, aching, tingling, numbness, pins and needles. Peripheral and
central neuropathic pain may
also be associated with mood changes, sleep disturbance, fatigue
(tiredness), and can have an impact
on physical and social functioning and overall quality of life.
EPILEPSY:
Pregabalin Pfizer is used to treat a certain form of epilepsy
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Pregabalin Pfizer 25 mg hard capsules
Pregabalin Pfizer 50 mg hard capsules
Pregabalin Pfizer 75 mg hard capsules
Pregabalin Pfizer 100 mg hard capsules
Pregabalin Pfizer 150 mg hard capsules
Pregabalin Pfizer 200 mg hard capsules
Pregabalin Pfizer 225 mg hard capsules
Pregabalin Pfizer 300 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pregabalin Pfizer 25 mg hard capsules
Each hard capsule contains 25 mg of pregabalin.
Pregabalin Pfizer 50 mg hard capsules
Each hard capsule contains 50 mg of pregabalin.
Pregabalin Pfizer 75 mg hard capsules
Each hard capsule contains 75 mg of pregabalin.
_ _
Pregabalin Pfizer 100 mg hard capsules
Each hard capsule contains 100 mg of pregabalin.
Pregabalin Pfizer 150 mg hard capsules
Each hard capsule contains 150 mg of pregabalin.
_ _
Pregabalin Pfizer 200 mg hard capsules
Each hard capsule contains 200 mg of pregabalin.
_ _
Pregabalin Pfizer 225 mg hard capsules
Each hard capsule contains 225 mg of pregabalin.
Pregabalin Pfizer 300 mg hard capsules
Each hard capsule contains 300 mg of pregabalin.
_ _
Excipients with known effect
Pregabalin Pfizer 25 mg hard capsules
Each hard capsule also contains 35 mg lactose monohydrate.
Pregabalin Pfizer 50 mg hard capsules
Each hard capsule also contains 70 mg lactose monohydrate.
Pregabalin Pfizer 75 mg hard capsules
Each hard capsule also contains 8.25 mg lactose monohydrate.
Pregabalin Pfizer 100 mg hard capsules
Each hard capsule also contains 11 mg lactose monohydrate.
Pregabalin Pfizer 150 mg hard capsules
Each hard capsule also contains 16.50 mg lactose monohydrate.
Pregabalin Pfizer 200 mg hard capsules
Each hard capsule also contains 22 mg lactose monohydrate.
3
Pregabalin Pfizer 225 mg hard capsules
Each hard capsule also contains 24.75 mg lactose monohydrate.
Pregabalin Pfizer 300 mg hard capsules
Each hard capsule also contains 33 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard cap
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel bulgariska 12-01-2024
Produktens egenskaper Produktens egenskaper bulgariska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport bulgariska 07-05-2014
Bipacksedel Bipacksedel spanska 12-01-2024
Produktens egenskaper Produktens egenskaper spanska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport spanska 07-05-2014
Bipacksedel Bipacksedel tjeckiska 12-01-2024
Produktens egenskaper Produktens egenskaper tjeckiska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport tjeckiska 07-05-2014
Bipacksedel Bipacksedel danska 12-01-2024
Produktens egenskaper Produktens egenskaper danska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport danska 07-05-2014
Bipacksedel Bipacksedel tyska 12-01-2024
Produktens egenskaper Produktens egenskaper tyska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport tyska 07-05-2014
Bipacksedel Bipacksedel estniska 12-01-2024
Produktens egenskaper Produktens egenskaper estniska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport estniska 07-05-2014
Bipacksedel Bipacksedel grekiska 12-01-2024
Produktens egenskaper Produktens egenskaper grekiska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport grekiska 07-05-2014
Bipacksedel Bipacksedel franska 12-01-2024
Produktens egenskaper Produktens egenskaper franska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport franska 07-05-2014
Bipacksedel Bipacksedel italienska 12-01-2024
Produktens egenskaper Produktens egenskaper italienska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport italienska 07-05-2014
Bipacksedel Bipacksedel lettiska 12-01-2024
Produktens egenskaper Produktens egenskaper lettiska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport lettiska 07-05-2014
Bipacksedel Bipacksedel litauiska 12-01-2024
Produktens egenskaper Produktens egenskaper litauiska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport litauiska 07-05-2014
Bipacksedel Bipacksedel ungerska 12-01-2024
Produktens egenskaper Produktens egenskaper ungerska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport ungerska 07-05-2014
Bipacksedel Bipacksedel maltesiska 12-01-2024
Produktens egenskaper Produktens egenskaper maltesiska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport maltesiska 07-05-2014
Bipacksedel Bipacksedel nederländska 12-01-2024
Produktens egenskaper Produktens egenskaper nederländska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport nederländska 07-05-2014
Bipacksedel Bipacksedel polska 12-01-2024
Produktens egenskaper Produktens egenskaper polska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport polska 07-05-2014
Bipacksedel Bipacksedel portugisiska 12-01-2024
Produktens egenskaper Produktens egenskaper portugisiska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport portugisiska 07-05-2014
Bipacksedel Bipacksedel rumänska 12-01-2024
Produktens egenskaper Produktens egenskaper rumänska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport rumänska 07-05-2014
Bipacksedel Bipacksedel slovakiska 12-01-2024
Produktens egenskaper Produktens egenskaper slovakiska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport slovakiska 07-05-2014
Bipacksedel Bipacksedel slovenska 12-01-2024
Produktens egenskaper Produktens egenskaper slovenska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport slovenska 07-05-2014
Bipacksedel Bipacksedel finska 12-01-2024
Produktens egenskaper Produktens egenskaper finska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport finska 07-05-2014
Bipacksedel Bipacksedel svenska 12-01-2024
Produktens egenskaper Produktens egenskaper svenska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport svenska 07-05-2014
Bipacksedel Bipacksedel norska 12-01-2024
Produktens egenskaper Produktens egenskaper norska 12-01-2024
Bipacksedel Bipacksedel isländska 12-01-2024
Produktens egenskaper Produktens egenskaper isländska 12-01-2024
Bipacksedel Bipacksedel kroatiska 12-01-2024
Produktens egenskaper Produktens egenskaper kroatiska 12-01-2024
Offentlig bedömningsrapport Offentlig bedömningsrapport kroatiska 07-05-2014

Sök varningar relaterade till denna produkt